Used in the pharmaceutical industry as a key intermediate in the synthesis of nicotinic acetylcholine receptor (nAChR) modulators. It is particularly valuable in developing compounds targeting neurological disorders such as Alzheimer's disease, Parkinson's disease, and schizophrenia. Its structural features enable selective interaction with receptor subtypes, enhancing cognitive function and neuronal signaling in preclinical studies. Also employed in research for novel antidepressants and treatments for nicotine addiction due to its ability to influence dopaminergic pathways.